Maryland SB78 mandates specific practices for providers and laboratories administering prostate-specific antigen tests.

Maryland SB78, known as the Protect Our Prostate Act, introduces new regulations for prostate-specific antigen testing. It requires providers to inform patients about necessary preparation for accurate test results. Laboratories must follow disclosure requirements, use standard calibration for testing assays, report results in a standard manner, and participate in recognized proficiency programs. The bill aims to ensure patients are adequately informed about the potential costs and implications of false-positive results.

Maryland SB78 mandates specific practices for providers and laboratories administering prostate-specific antigen tests.

Maryland SB78, known as the Protect Our Prostate Act, introduces new regulations for prostate-specific antigen testing. It requires providers to inform patients about necessary preparation for accurate test results. Laboratories must follow disclosure requirements, use standard calibration for testing assays, report results in a standard manner, and participate in recognized proficiency programs. The bill aims to ensure patients are adequately informed about the potential costs and implications of false-positive results.